(19)
(11) EP 1 335 707 A2

(12)

(88) Date of publication A3:
03.10.2002

(43) Date of publication:
20.08.2003 Bulletin 2003/34

(21) Application number: 01273804.3

(22) Date of filing: 23.10.2001
(51) International Patent Classification (IPC)7A61K 9/22, A61K 9/26, A61K 9/30, A61K 9/52, A61K 9/58, A61K 9/62
(86) International application number:
PCT/US0150/872
(87) International publication number:
WO 0206/5834 (29.08.2002 Gazette 2002/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 24.10.2000 US 242911 P

(71) Applicant: SmithKline Beecham Corporation
King of Prussia, PA 19406 (US)

(72) Inventors:
  • ANDRONIS, Vlassios
    King of Prussia, PA 19406 (US)
  • LAMEY, Kimberly, A.
    King of Prussia, PA 19406 (US)
  • OH, Choon, K.
    Collegeville, PA 19426 (US)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) NOVEL FORMULATIONS OF CARVEDILOL